日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect Comparison

在接受过三类药物治疗且既往接受过 2-4 线治疗的复发/难治性多发性骨髓瘤患者中，西他卡巴基因 Autoleucel 与艾达卡巴基因 Vicleucel 的疗效比较：更新的匹配调整间接比较

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03479-y
Lopez-Muñoz, Nieves; Bar, Noffar; Diels, Joris; van Sanden, Suzy; Mendes, João; Lee, Seina; Hernando, Teresa; Lendvai, Nikoletta; Patel, Nitin; Ishida, Tadao; Er, Jeremy; Harrison, Simon J
多发性骨髓瘤
骨髓瘤
发表日期：2026
文献求助 收藏

Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison

Ciltacabtagene Autoleucel 与标准治疗方案治疗既往接受过治疗的复发或难治性多发性骨髓瘤患者的疗效比较：一项匹配调整的间接比较研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03205-8
Puig, Noemi; Diels, Joris; van Sanden, Suzy; Mendes, João; Burnett, Heather; Cichewicz, Allie; Lee, Seina; Hernando, Teresa; Schecter, Jordan M; Lendvai, Nikoletta; Patel, Nitin; Sanchez-Pina, José María; Rocchi, Serena; Mina, Roberto; Corradini, Paolo; Cavo, Michele; Miguel, Jesús San; Shune, Leyla; Khan, Abdullah M; Sidana, Surbhi; Leleu, Xavier; Manier, Salomon; Lipe, Brea; Weisel, Katja; Martinez-Lopez, Joaquin
多发性骨髓瘤
骨髓瘤
发表日期：2025
文献求助 收藏

Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer

Artemis® 的最终分析，这是一项欧洲真实世界回顾性研究，旨在评估阿帕鲁胺治疗转移性激素敏感性前列腺癌患者的疗效。

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-025-14294-7
Boegemann, Martin; Bennamoun, Mostefa; Dourthe, Louis Marie; Encarnacion, Juan Antonio; Hegele, Axel; Hellmis, Eva; Latorzeff, Igor; Leicht, Wolfgang; Oñate-Celdrán, Julián; Rosino-Sánchez, Antonio; Hanna, Krystelle; Lencart, Joana; Lukac, Martin; Schioppa, Claudio A; Van Sanden, Suzy; Kramer, Gero
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

A network meta-analysis of the safety of systemic treatments in patients with metastatic hormone-sensitive prostate cancer

一项关于转移性激素敏感性前列腺癌患者全身治疗安全性的网络荟萃分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1468928
Di Maio, Massimo; Gonzalez-Billalabeitia, Enrique; Marandino, Laura; Maroto, Pablo; Timsit, Marc-Olivier; Luccarini, Irene; Robinson, Paul; Van Sanden, Suzy; Hadaschik, Boris A
肿瘤
前列腺癌
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

A Matching-Adjusted Indirect Comparison of Guselkumab and Secukinumab in Patients with Psoriatic Arthritis Over 52 Weeks

一项针对银屑病关节炎患者，采用匹配调整法对古塞库单抗和司库奇尤单抗进行为期 52 周的间接比较研究

期刊:Rheumatology and Therapy
影响因子:2.9
doi:10.1007/s40744-025-00771-9
van Sanden, Suzy; Schubert, Agata; Patel, Barkha P; Zimmermann, Miriam; Hassan, Fareen
关节炎
银屑病
发表日期：2025
文献求助 收藏

Feasibility of Indirect Treatment Comparisons Between Niraparib Plus Abiraterone Acetate and Other First-Line Poly ADP-Ribose Polymerase Inhibitor Treatment Regimens for Patients with BRCA1/2 Mutation-Positive Metastatic Castration-Resistant Prostate Cancer

对携带 BRCA1/2 突变的转移性去势抵抗性前列腺癌患者，比较尼拉帕尼联合醋酸阿比特龙与其他一线聚 ADP 核糖聚合酶抑制剂治疗方案的间接治疗可行性

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-02918-6
De Santis, Maria; Breijo, Sara Martínez; Robinson, Paul; Capone, Camille; Pascoe, Katie; Van Sanden, Suzy; Hashim, Mahmoud; Trevisan, Marco; Daly, Caitlin; Reitsma, Friso; van Beekhuizen, Sophie; Ruan, Haoyao; Heeg, Bart; Verzoni, Elena
BRCA1
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

PB2014: TECLISTAMAB VS SELINEXOR-DEXAMETHASONE IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MATCHING-ADJUSTED INDIRECT COMPARISON

PB2014：TECLISTAMAB 与 SELINEXOR-DEXAMETHASONE 在接受过三类抗骨髓瘤治疗的复发/难治性多发性骨髓瘤患者中的比较：一项匹配调整的间接比较研究

期刊:Chemical Reviews
影响因子:55.8
doi:10.1021/cr2000477
Potyrailo, Radislav A; Surman, Cheryl; Nagraj, Nandini; Burns, Andrew; Rosinol, L; Usmani, S Z; Bahlis, N; Krishnan, A Y; Nooka, A K; Oriol, A; Delforge, M; Garfall, A L; van de Donk, N W; Rodríguez Otero, P; Martin, T G; Diels, J; Van Sanden, S; Pei, L; Ammann, E; Kobos, R; Slavcev, M; Smit, J; Londhe, A; Moreau, P
多发性骨髓瘤
TEC
MET
骨髓瘤
发表日期：2022
文献求助 收藏

Prevalence of Epidermal Growth Factor Receptor Exon 20 Insertion Mutations in Non-small-Cell Lung Cancer in Europe: A Pragmatic Literature Review and Meta-analysis

欧洲非小细胞肺癌中表皮生长因子受体20号外显子插入突变的患病率：一项实用性文献综述和荟萃分析

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-022-00868-z
Van Sanden, Suzy; Murton, Molly; Bobrowska, Anna; Rahhali, Nora; Sermon, Jan; Rodrigues, Bernardo; Goff-Leggett, Danielle; Chouaid, Christos; Sebastian, Martin; Greystoke, Alastair
肺癌
肿瘤
肿瘤免疫
信号转导
细胞生物学
发表日期：2022
文献求助 收藏

Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison

阿帕鲁胺与达罗鲁胺治疗非转移性去势抵抗性前列腺癌的疗效和耐受性比较：一项匹配调整间接比较研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-021-01885-6
Chowdhury, Simon; Oudard, Stephane; Uemura, Hiroji; Joniau, Steven; Dearden, Lindsay; Capone, Camille; Van Sanden, Suzy; Diels, Joris; Hadaschik, Boris A
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON

P898：采用匹配调整的间接治疗比较方法，比较 TECLISTAMAB 与 BELANTAMAB MAFODOTIN 在接受过三类药物治疗的复发/难治性多发性骨髓瘤患者中的疗效

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/1471-2458-7-102
Sung, Tzu-I; Chen, Pau-Chung; Jyuhn-Hsiarn Lee, Lukas; Lin, Yi-Ping; Hsieh, Gong-Yih; Wang, Jung-Der; Weisel, K; Mateos, M-V; Vincent, L; Martin, T; Berdeja, J G; Jakubowiak, A; Jagannath, S; Lin, Y; Thilakarathne, P; Ghilotti, F; Diels, J; Haefliger, B; Hague, C; Gonzalez, A; Schecter, J M; Gries, K S; Strulev, V; Nesheiwat, T; Pacaud, L; Einsele, H; Moreau, P; Delforge, M; Usmani, S Z; van de Donk, N W; Garfall, A L; Moreau, P; Oriol, A; Nooka, A K; Rosinol, L; Bahlis, N; Rodriguez-Otero, P; Martin, T; Diels, J; Van Sanden, S; Pei, L; Ammann, E; Kobos, R; Slavcev, M; Smit, J; Londhe, A; Krishnan, A
MAF
NTA
多发性骨髓瘤
TEC
骨髓瘤
发表日期：2022
文献求助 收藏